儿童医疗保健市场规模、份额和成长分析(按疾病类型、治疗领域、治疗方法和地区划分)-2026-2033年产业预测
市场调查报告书
商品编码
1899487

儿童医疗保健市场规模、份额和成长分析(按疾病类型、治疗领域、治疗方法和地区划分)-2026-2033年产业预测

Pediatric Healthcare Market Size, Share, and Growth Analysis, By Diseases Type (Short Term Diseases, Chronic Diseases), By Therapeutics (Cardiology, Allergy And Immunology), By Treatment, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到 2024 年,全球儿童医疗保健市场规模将达到 136.6 亿美元,到 2025 年将达到 142.6 亿美元,到 2033 年将达到 201.2 亿美元,预测期(2026-2033 年)的复合年增长率为 4.4%。

全球儿童医疗保健市场是一个充满活力且快速发展的行业,致力于透过各种医疗服务、治疗方法和产品来改善儿童的健康和福祉。人口年轻化和人们对儿童医疗保健挑战的认识不断提高是推动市场成长的主要因素。关键成长要素包括技术创新、医疗费用支出增加以及对预防性护理日益重视。该市场涵盖满足儿童特定医疗需求的各个细分领域,包括诊断、治疗、疫苗、医疗设备和支援服务。该市场的特点是跨国公司、区域性企业和创新新兴企业之间竞争激烈,它们都试图透过研发、策略联盟、併购和产品发布来获取市场份额,最终塑造专业儿童医疗保健的未来发展方向。

全球儿童医疗保健市场驱动因素

全球儿童医疗保健市场的主要驱动力之一是人们对预防性医疗保健的日益重视。人们越来越认识到早期发现、及时介入和预防措施在保护儿童健康方面的重要作用。这种意识源于减少儿童疾病长期影响和改善儿童整体健康状况的需要。定期体检、疫苗接种和健康检查等预防性医疗保健措施正日益受到重视,这些措施能够及早发现并解决潜在的健康问题,从而确保儿童未来的健康成长。

全球儿童医疗保健市场面临的限制因素

全球儿童医疗保健市场面临的主要挑战之一是为儿童提供专业服务和治疗的高昂成本。提供专业护理通常需要先进的技术、特製药物以及具备小儿科知识的医护人员,所有这些都会增加成本。这种经济负担对家庭来说尤其沉重,尤其是在缺乏经济实惠的医疗保健选择和充足保险覆盖的地区。因此,高昂的费用可能会使一些儿童无法获得高品质的医疗保健。这可能导致医疗保健结果的差异,并阻碍整个市场的成长。解决这些与成本相关的问题对于促进公平地获得儿童医疗保健至关重要。

全球儿童医疗保健市场趋势

全球儿童医疗保健市场的一大趋势是日益重视针对儿童的个人化和精准医疗。这种方法认识到儿童群体独特的生理、遗传和发育特征,并优先考虑根据每位儿童的个别特征和需求量身定制医疗干预措施。基因组学、分子诊断和生物标记识别等技术进步正在推动这项变革,使医疗服务提供者能够实施更具针对性和个人化的治疗策略。透过关注这些独特的生物学和遗传变异,这一趋势旨在提高治疗效果、减少副作用,并最终改善儿童医疗机构的整体患者照护。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数(2025)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 监管环境
  • 案例研究
  • 技术进步

全球儿童医疗保健市场规模(按疾病类型和复合年增长率划分)(2026-2033 年)

  • 短期疾病
  • 慢性病
  • 其他的

全球儿童医疗保健市场规模(依治疗领域划分)及复合年增长率(2026-2033 年)

  • 心臟病学
  • 过敏与免疫学
  • 胃肠病学
  • 感染疾病
  • 其他的

全球儿童医疗保健市场规模(按治疗方法和复合年增长率划分)(2026-2033 年)

  • 疫苗
  • 药品
  • 外科手术
  • 其他的

全球儿童医疗保健市场规模(按地区划分)及复合年增长率(2026-2033 年)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位(2025 年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析(2025 年)
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Eli Lilly and Company(United States)
  • Maven(United States)
  • InStride Health(United States)
  • Shorla Oncology(Ireland)
  • Amgen(United States)
  • Backpack Healthcare(United States)
  • Moderna Therapeutics(United States)
  • Summer Health(United States)
  • Novartis AG(Switzerland)
  • AstraZeneca(United Kingdom)
  • Bristol-Myers Squibb Company(United States)
  • AMMT(United Arab Emirates)
  • King Faisal Specialist Hospital and Research Centre(Saudi Arabia)
  • VPS Healthcare(United Arab Emirates)
  • Creche Innovations(United States)
  • Bodypoint(United States)
  • Dechoker(United States)
  • eBroselow(United States)
  • Graco Children Products(United States)

结论与建议

简介目录
Product Code: SQMIG35I2175

Global Pediatric Healthcare Market size was valued at USD 13.66 Billion in 2024 and is poised to grow from USD 14.26 Billion in 2025 to USD 20.12 Billion by 2033, growing at a CAGR of 4.4% during the forecast period (2026-2033).

The global pediatric healthcare market represents a vibrant and rapidly evolving sector that focuses on enhancing the health and well-being of children through a diverse array of medical services, treatments, and products. Growth is being propelled by a rising youth population and greater awareness of pediatric health challenges. Key drivers include technological innovation, heightened healthcare spending, and an emphasis on preventive care. This market encompasses various segments such as diagnostics, therapeutics, vaccines, medical devices, and support services, designed to address the unique healthcare needs of children. It is characterized by intense competition among multinational corporations, regional entities, and innovative startups aiming for market share through R&D, strategic alliances, mergers, and product launches, ultimately shaping a future focused on specialized pediatric care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pediatric Healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pediatric Healthcare Market Segments Analysis

Global Pediatric Healthcare Market is segmented by diseases type, therapeutics, treatment and region. Based on diseases type, the market is segmented into short term diseases, chronic diseases and others. Based on therapeutics, the market is segmented into cardiology, allergy & immunology, gastroenterology, infectious disease and others. Based on treatment, the market is segmented into vaccines, medication/ drugs, surgery and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pediatric Healthcare Market

A significant driving force behind the global pediatric healthcare market is the heightened awareness and focus on preventive care. There is an increasing understanding of the critical role that early detection, prompt interventions, and proactive measures play in safeguarding children's health. This awareness is motivated by the need to reduce the long-term effects of pediatric illnesses and enhance the overall well-being of young patients. Initiatives centered on preventive care, such as regular check-ups, vaccinations, and health screenings, are gaining priority to identify and tackle potential health concerns early on, ensuring healthier outcomes for children in the future.

Restraints in the Global Pediatric Healthcare Market

A significant challenge facing the global pediatric healthcare market is the elevated expense associated with providing services and treatments specifically for children. Delivering specialized care often requires advanced technologies, unique medications, and healthcare professionals with expertise in pediatrics, all of which contribute to increased costs. This financial burden can be particularly heavy for families, especially in areas where affordable healthcare options or adequate insurance coverage are lacking. Consequently, the high expenses may restrict access to quality care for some children, leading to disparities in healthcare outcomes and potentially hindering overall market growth. Addressing these cost-related issues is crucial for promoting equitable access to pediatric healthcare.

Market Trends of the Global Pediatric Healthcare Market

A prominent trend in the global pediatric healthcare market is the increasing emphasis on personalized and precision medicine tailored specifically for children. This approach prioritizes customizing medical interventions based on the individual characteristics and needs of young patients, acknowledging the distinctive physiological, genetic, and developmental traits inherent in pediatric populations. Advancements in technologies like genomics, molecular diagnostics, and biomarker identification are driving this shift, allowing healthcare providers to implement more targeted and individualized treatment strategies. By focusing on these unique biological and genetic variations, the trend aims to enhance treatment efficacy, reduce adverse effects, and ultimately improve overall patient care in pediatric healthcare settings.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies
  • Technological Advancement

Global Pediatric Healthcare Market Size by Diseases Type & CAGR (2026-2033)

  • Market Overview
  • Short Term Diseases
  • Chronic Diseases
  • Others

Global Pediatric Healthcare Market Size by Therapeutics & CAGR (2026-2033)

  • Market Overview
  • Cardiology
  • Allergy And Immunology
  • Gastroenterology
  • Infectious Disease
  • Others

Global Pediatric Healthcare Market Size by Treatment & CAGR (2026-2033)

  • Market Overview
  • Vaccines
  • Medication/ Drugs
  • Surgery
  • Others

Global Pediatric Healthcare Market Size & CAGR (2026-2033)

  • North America (Diseases Type, Therapeutics, Treatment)
    • US
    • Canada
  • Europe (Diseases Type, Therapeutics, Treatment)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Diseases Type, Therapeutics, Treatment)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Diseases Type, Therapeutics, Treatment)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Diseases Type, Therapeutics, Treatment)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Eli Lilly and Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Maven (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • InStride Health (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shorla Oncology (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amgen (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Backpack Healthcare (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Moderna Therapeutics (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Summer Health (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AstraZeneca (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bristol-Myers Squibb Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AMMT (United Arab Emirates)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • King Faisal Specialist Hospital and Research Centre (Saudi Arabia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • VPS Healthcare (United Arab Emirates)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Creche Innovations (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bodypoint (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dechoker (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • eBroselow (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Graco Children Products (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations